0,933  0,003  Cardiovascular analeptic
0,857  0,010  Apoptosis agonist
0,825  0,012  Antiinflammatory
0,740  0,005  Nitric oxide antagonist
0,727  0,017  Antineoplastic (breast cancer)
0,714  0,005  Cardioprotectant
0,682  0,005  Antineoplastic (pancreatic cancer)
0,618  0,007  Tumour necrosis factor alpha release inhibitor
0,591  0,011  AR expression inhibitor
0,579  0,007  UGT1A4 substrate
0,584  0,015  Immunosuppressant
0,558  0,008  Vascular (periferal) disease treatment
0,549  0,003  Vasopressin 1A antagonist
0,538  0,003  Vasopressin 1 antagonist
0,535  0,004  Antiviral (Influenza A)
0,543  0,023  Respiratory analeptic
0,536  0,022  5 Hydroxytryptamine release stimulant
0,518  0,005  Antiviral (Herpes)
0,540  0,038  Antineoplastic (lung cancer)
0,505  0,005  Contraceptive
0,501  0,004  Lipocortins synthesis antagonist
0,498  0,005  Antiviral (Influenza)
0,500  0,011  Antineoplastic (endocrine cancer)
0,490  0,003  Oxytocin antagonist
0,507  0,021  Hepatic disorders treatment
0,509  0,026  Bone diseases treatment
0,495  0,012  Renal disease treatment
0,500  0,020  NOS3 expression inhibitor
0,522  0,052  Caspase 9 stimulant
0,503  0,032  Aldehyde oxidase inhibitor
0,501  0,033  Antipruritic, allergic
0,472  0,013  Skin irritative effect
0,461  0,007  Prostate disorders treatment
0,467  0,016  UGT2B4 substrate
0,449  0,002  Vasopressin 2 antagonist
0,483  0,042  Rheumatoid arthritis treatment
0,444  0,004  Antidiuretic hormone antagonist
0,454  0,014  Antihypoxic
0,442  0,010  Abortion inducer
0,455  0,026  Sensitization
0,456  0,028  Analeptic
0,436  0,009  Sodium/bile acid cotransporter inhibitor
0,434  0,010  Antiparkinsonian, rigidity relieving
0,452  0,030  Antineoplastic (melanoma)
0,468  0,055  TNF expression inhibitor
0,418  0,009  Antiacne
0,456  0,049  Antileukemic
0,455  0,052  Transcription factor NF kappa B inhibitor
0,403  0,014  5 Hydroxytryptamine uptake stimulant
0,395  0,012  Prostatic (benign) hyperplasia treatment
0,412  0,030  NOS2 expression inhibitor
0,389  0,011  Interferon gamma antagonist
0,412  0,042  FMO1 substrate
0,407  0,036  Apoptosis antagonist
0,382  0,012  Antipruritic, non-allergic
0,411  0,043  Antineoplastic (non-Hodgkin's lymphoma)
0,371  0,008  Endometrios treatment
0,373  0,010  UGT2B15 substrate
0,434  0,073  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,366  0,005  UGT2B9 substrate
0,400  0,040  ICAM1 expression inhibitor
0,404  0,061  CYP3A4 substrate
0,372  0,037  Calcium channel activator
0,403  0,076  5 Hydroxytryptamine release inhibitor
0,387  0,065  Ulceration
0,380  0,058  Antineoplastic (colorectal cancer)
0,371  0,057  Cholesterol antagonist
0,327  0,013  Diabetic nephropathy treatment
0,331  0,021  UGT2B7 substrate
0,366  0,055  Antifungal
0,354  0,045  UGT1A9 substrate
0,359  0,054  Antineoplastic (ovarian cancer)
0,353  0,049  CTGF expression inhibitor
0,347  0,046  Antineoplastic (glioma)
0,326  0,030  UDP-glucuronosyltransferase substrate
0,302  0,010  Antifungal enhancer
0,294  0,005  UGT2B10 substrate
0,294  0,013  Renal failure treatment
0,308  0,028  Gastrin inhibitor
0,319  0,039  Chemopreventive
0,312  0,033  Ca(v)3.3 blocker
0,329  0,052  Antioxidant
0,308  0,032  Platelet adhesion inhibitor
0,314  0,039  GST M1-1 substrate
0,348  0,082  CYP2C9 substrate
0,305  0,043  UGT1A6 substrate
0,349  0,087  GST A substrate
0,266  0,004  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,349  0,087  GABA C receptor rho-3 antagonist
0,265  0,005  Antirickettsial
0,326  0,067  Antineoplastic (colon cancer)
0,286  0,028  Antialcoholic
0,300  0,043  Psychostimulant
0,312  0,061  Antiosteoporotic
0,254  0,008  Contraceptive female
0,282  0,037  UGT1A1 substrate
0,303  0,060  Antihypercholesterolemic
0,265  0,022  Bone formation stimulant
0,245  0,007  Arachidonic acid antagonist
0,262  0,026  Hair growth stimulant
0,313  0,080  Prostate cancer treatment
0,260  0,033  Neurotrophic factor enhancer
0,244  0,019  Cholesterol synthesis inhibitor
0,282  0,057  Cardiodepressant
0,271  0,049  Mutagenic
0,291  0,070  CYP2C19 substrate
0,251  0,032  Antiviral (Hepatitis)
0,223  0,007  Adenylate cyclase stimulant
0,226  0,011  Antispirochetal
0,276  0,062  Hypoglycemic
0,258  0,047  Anesthetic general
0,216  0,007  Pregnane X receptor agonist
0,347  0,139  Autoimmune disorders treatment
0,267  0,060  Potassium channel (Voltage-sensitive) blocker
0,214  0,008  Transcription factor NF kappa B stimulant
0,269  0,067  Antineoplastic (cervical cancer)
0,243  0,045  Hepatoprotectant
0,232  0,036  UGT1A3 substrate
0,195  0,002  Heme oxygenase stimulant
0,274  0,081  FMO3 substrate
0,229  0,038  Acaricide
0,194  0,005  UGT2B11 substrate
0,206  0,017  SULT1A1 substrate
0,207  0,018  Microtubule formation inhibitor
0,231  0,044  Antimutagenic
0,190  0,004  Vasopressin 1B antagonist
0,255  0,070  Antiprotozoal (Leishmania)
0,256  0,072  Proliferative diseases treatment
0,305  0,121  Histamine release inhibitor
0,208  0,026  Antiviral (Hepatitis B)
0,208  0,026  DNA polymerase I inhibitor
0,217  0,037  Antiparkinsonian, tremor relieving
0,189  0,011  ABCA1 expression enhancer
0,184  0,006  Anabolic
0,228  0,052  Pneumotoxic
0,280  0,107  Vasodilator, peripheral
0,251  0,078  Interleukin agonist
0,248  0,076  Superoxide dismutase inhibitor
0,176  0,004  Aldosterone antagonist
0,233  0,062  RNA-directed DNA polymerase inhibitor
0,174  0,008  Paget's disease treatment
0,253  0,088  Antidiabetic (type 2)
0,249  0,084  Transcription factor STAT3 inhibitor
0,176  0,014  Actinic keratosis treatment
0,239  0,079  Tyrosine 3 hydroxylase inhibitor
0,204  0,046  Succinate dehydrogenase inhibitor
0,237  0,080  Teratogen
0,245  0,088  Chemoprotective
0,225  0,069  Cytotoxic
0,233  0,080  DNA synthesis inhibitor
0,169  0,018  Androgen antagonist
0,218  0,069  VCAM1 expression inhibitor
0,244  0,096  Radioprotector
0,191  0,043  Anesthetic
0,158  0,011  Postmenopausal disorders treatment
0,176  0,029  Antismoking
0,153  0,009  Glutamate release inhibitor
0,229  0,085  Antineoplastic (liver cancer)
0,255  0,112  CYP3A4 inhibitor
0,163  0,020  Ca2+-transporting ATPase inhibitor
0,199  0,057  VEGF expression inhibitor
0,154  0,013  Aromatase inhibitor
0,163  0,021  Antiinfertility, female
0,188  0,048  Phobic disorders treatment
0,252  0,116  Interleukin 2 agonist
0,183  0,048  Protein kinase stimulant
0,176  0,042  Alpha-N-acetylglucosaminidase inhibitor
0,194  0,060  LDLR expression enhancer
0,152  0,019  Potassium channel activator
0,217  0,085  Antihypotensive
0,216  0,085  Embryotoxic
0,228  0,098  Flavin-containing monooxygenase substrate
0,159  0,029  Choleretic
0,236  0,107  Antineoplastic (multiple myeloma)
0,144  0,015  Keratolytic
0,142  0,015  Tocolytic
0,135  0,008  Narcotic antagonist
0,134  0,009  Androgen agonist
0,156  0,032  GABA C receptor agonist
0,198  0,074  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,158  0,035  Carcinogenic, group 2B
0,212  0,089  Cytostatic
0,192  0,070  P-glycoprotein inhibitor
0,159  0,037  Autism spectrum disorders treatment
0,132  0,011  Na+ K+ transporting ATPase inhibitor
0,141  0,021  GST T1-1 substrate
0,180  0,061  Toxic, respiratory center
0,278  0,159  Analgesic
0,127  0,008  5-Alpha-reductase inhibitor
0,174  0,056  Melanin inhibitor
0,122  0,004  Postcoital contraceptive
0,151  0,033  Alcohol dehydrogenase substrate
0,149  0,032  TRPA1 agonist
0,123  0,005  RNA-directed RNA polymerase stimulant
0,179  0,062  Phospholipase C inhibitor
0,163  0,048  Antiseptic
0,136  0,021  SULT1E1 substrate
0,134  0,019  Tourette's syndrome treatment
0,119  0,004  Anesthetic inhalation
0,128  0,014  Glycine receptor antagonist
0,133  0,020  Antidote, mercury
0,150  0,038  Menstruation disorders treatment
0,116  0,005  SULT2A1 substrate
0,116  0,004  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,151  0,040  Glutathione S-transferase substrate
0,173  0,063  Antiviral (Hepatitis C)
0,142  0,033  UGT2B1 substrate
0,121  0,012  Glycine receptor agonist
0,127  0,019  Contraceptive male
0,128  0,020  Ornithine decarboxylase inhibitor
0,161  0,054  SULT1A3 substrate
0,175  0,069  Antipruritic
0,140  0,034  Antineoplastic, alkylator
0,140  0,036  GABA C receptor antagonist
0,135  0,032  Antineoplastic alkaloid
0,146  0,043  Coagulant
0,135  0,033  Estrogen antagonist
0,196  0,095  Potassium channel blocker
0,105  0,004  Adenylate cyclase 1 inhibitor
0,190  0,091  Antineoplastic (glioblastoma multiforme)
0,107  0,009  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,121  0,024  Inducible nitric-oxide synthase inhibitor
0,109  0,014  Anticholelithogenic
0,177  0,081  Carcinogenic
0,184  0,090  Insulin sensitizer
0,126  0,034  Prolactin inhibitor
0,113  0,021  Estrogen receptor alpha antagonist
0,212  0,121  Transcription factor STAT inhibitor
0,109  0,018  Cushing's syndrome treatment
0,144  0,055  Retinoprotector
0,167  0,078  Muscle relaxant
0,151  0,064  Skeletal muscle relaxant
0,138  0,053  Adenylate cyclase inhibitor
0,207  0,122  Amyotrophic lateral sclerosis treatment
0,154  0,069  CF transmembrane conductance regulator agonist
0,216  0,133  Hypoxia-inducible factor 1 alpha inhibitor
0,087  0,005  Pregnane X receptor antagonist
0,091  0,008  Lipocortins synthesis agonist
0,135  0,053  CC chemokine 6 receptor antagonist
0,104  0,022  Premenstrual syndrome treatment
0,103  0,021  Estrogen-related receptor beta agonist
0,096  0,015  Uterine relaxant
0,106  0,026  Nicotinic alpha4beta2 receptor antagonist
0,197  0,117  DNA damaging
0,084  0,005  Farnesoid X receptor agonist
0,116  0,037  Estrogen receptor beta antagonist
0,104  0,026  CDC25A inhibitor
0,231  0,153  Vasodilator, coronary
0,087  0,010  Potassium channel Kv1.3 blocker
0,137  0,060  Antihemorrhagic
0,134  0,059  Vanilloid 1 agonist
0,172  0,096  CYP2B6 inhibitor
0,091  0,016  Antimycoplasmal
0,095  0,020  Antidote, organophosphates
0,131  0,057  Growth stimulant
0,126  0,053  Antifungal (Pneumocystis)
0,092  0,019  Estrogen agonist
0,134  0,063  Cyclooxygenase 3 inhibitor
0,112  0,041  Antineoplastic antibiotic
0,119  0,049  Acetylcholine release stimulant
0,076  0,007  Glucocorticoid antagonist
0,144  0,075  Genotoxic
0,175  0,106  Antiparasitic
0,087  0,018  Cannabinoid CB2 receptor antagonist
0,079  0,011  Progesterone antagonist
0,115  0,049  Sulfotransferase substrate
0,132  0,065  Antihyperlipoproteinemic
0,105  0,039  Bile acid receptor antagonist
0,079  0,013  Estradiol 17 beta-dehydrogenase inhibitor
0,071  0,006  Parathyroid hormone antagonist
0,069  0,005  CXC chemokine 3 receptor antagonist
0,177  0,113  5 Hydroxytryptamine 3E antagonist
0,110  0,046  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,135  0,073  Farnesoid X receptor antagonist
0,077  0,014  Nicotinic alpha3beta2 receptor antagonist
0,068  0,006  5-Alpha-reductase 2 inhibitor
0,238  0,176  Antiprotozoal
0,066  0,008  GABA uptake inhibitor
0,110  0,052  Anticataract
0,118  0,060  Photosensitizer
0,182  0,125  Antipyretic
0,069  0,014  Estrogen receptor alpha agonist
0,117  0,062  Antiviral (CMV)
0,061  0,007  Glucose-6-phosphate dehydrogenase inhibitor
0,061  0,006  5-Alpha-reductase 1 inhibitor
0,079  0,025  Glutamate (mGluR6) antagonist
0,061  0,008  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,128  0,075  Cocaine dependence treatment
0,062  0,010  Guanylate cyclase inhibitor
0,183  0,131  Immunostimulant
0,154  0,102  Sedative
0,172  0,121  Antineoplastic (lymphoma)
0,196  0,146  CYP2D6 substrate
0,093  0,044  Acetylcholine nicotinic antagonist
0,140  0,092  Pulmonary hypertension treatment
0,104  0,056  UDP-glucose 4-epimerase inhibitor
0,118  0,070  Antiviral (Influenza B)
0,237  0,189  Antibacterial
0,143  0,095  Uterine stimulant
0,117  0,070  Beta amyloid protein antagonist
0,053  0,007  Tubulin agonist
0,055  0,009  Heme oxygenase inhibitor
0,137  0,091  Eye irritation, high
0,108  0,063  Ferrochelatase inhibitor
0,074  0,029  NMDA 2C receptor antagonist
0,115  0,070  Proteasome inhibitor
0,074  0,030  Antihemophilic
0,069  0,025  Bombesin 3 receptor antagonist
0,199  0,155  CYP1A2 substrate
0,253  0,210  Cyclophilin D inhibitor
0,253  0,210  Antidiabetic
0,116  0,073  Carcinogenic, group 3
0,172  0,130  Vasodilator
0,101  0,060  Dementia treatment
0,095  0,053  Triose-phosphate isomerase inhibitor
0,103  0,062  Adenylate kinase inhibitor
0,208  0,167  Antithrombotic
0,099  0,057  Lanosterol 14 alpha demethylase inhibitor
0,135  0,095  Heat shock protein 70 antagonist
0,048  0,008  Estrone sulfatase inhibitor
0,099  0,058  Vascular dementia treatment
0,057  0,018  Estrogen receptor beta agonist
0,080  0,042  Epoxide hydrolase inhibitor
0,053  0,016  Retinoid X receptor agonist
0,056  0,020  Microtubule stabilization
0,057  0,022  Mineralocorticoid receptor antagonist
0,104  0,069  DOPA decarboxylase inhibitor
0,040  0,005  Progesterone agonist
0,129  0,095  Diuretic
0,036  0,002  Telomerase stimulant
0,124  0,091  Pancreatic disorders treatment
0,100  0,068  Gout treatment
0,038  0,005  Hedgehog signaling activator
0,040  0,007  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,078  0,045  Vanilloid 4 agonist
0,047  0,015  Retinoid X alpha receptor agonist
0,047  0,015  Potassium channel Kv1.1 blocker
0,046  0,016  Retinoid X receptor antagonist
0,084  0,054  Antiviral (RSV)
0,099  0,069  Expectorant
0,137  0,108  Carcinogenic, group 1
0,140  0,112  Hearing loss treatment
0,074  0,045  Phosphofructokinase-1 inhibitor
0,049  0,020  Liver X receptor alpha agonist
0,132  0,104  Growth hormone agonist
0,041  0,014  Retinoid X alpha receptor antagonist
0,104  0,078  Nav1.5 sodium channel blocker
0,036  0,010  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,070  0,043  Glutamate (mGluR7) antagonist
0,165  0,139  Antiviral (Ebola)
0,107  0,082  Mental retardation treatment
0,086  0,062  Sodium/hydrogen exchanger 5 inhibitor
0,056  0,033  Alpha-mannosidase inhibitor
0,038  0,015  Carboxypeptidase B inhibitor
0,058  0,036  Acetyl-CoA transferase 2 inhibitor
0,060  0,038  Botulinum neurotoxin type A inhibitor
0,066  0,044  Hypercalcemia treatment
0,029  0,007  Corticosteroid-like
0,029  0,007  Vitamin D receptor antagonist
0,030  0,008  GRP78 expression inhibitor
0,051  0,030  HCV NS3/NS4A protease inhibitor
0,050  0,029  Glucose-6-phosphate isomerase inhibitor
0,036  0,015  Glutamate (mGluR3) agonist
0,044  0,025  Hypogonadism treatment
0,070  0,052  Phospholipase D inhibitor
0,170  0,152  Nitric-oxide synthase stimulant
0,063  0,046  Hyperparathyroidism treatment
0,042  0,024  Membrane dipeptidase inhibitor
0,024  0,008  Progesterone receptor B antagonist
0,129  0,113  Antihelmintic (Nematodes)
0,033  0,017  Liver X receptor beta antagonist
0,045  0,029  Geranyltranstransferase inhibitor
0,117  0,102  Psychosexual dysfunction treatment
0,018  0,003  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,027  0,012  Retinoid X gamma receptor agonist
0,053  0,039  Cannabinoid CB2 receptor agonist
0,061  0,046  Nitric oxide donor
0,023  0,009  Retinoid X beta receptor antagonist
0,095  0,081  Excitatory amino acid transporter EAAC1 inhibitor
0,029  0,015  Nicotinic acid receptor 2 antagonist
0,043  0,029  Alpha 1L adrenoreceptor agonist
0,091  0,077  Nitric-oxide synthase inhibitor
0,055  0,041  Argininosuccinate synthase inhibitor
0,082  0,070  NADH dehydrogenase inhibitor
0,132  0,120  Movement disorders treatment
0,115  0,104  Nav1.6 sodium channel blocker
0,028  0,016  Retinoid X gamma receptor antagonist
0,032  0,021  ATP citrate lysase inhibitor
0,091  0,079  Antiviral (Poxvirus)
0,019  0,008  NMDA receptor phencyclidine site antagonist
0,057  0,046  Sphingosine kinase inhibitor
0,090  0,080  Nav1.1 sodium channel blocker
0,014  0,004  Progesterone receptor A antagonist
0,026  0,016  Vanilloid 2 agonist
0,078  0,069  Sleep apnea treatment
0,023  0,014  Retinoic acid gamma receptor agonist
0,040  0,031  Cholesterol absorption inhibitor
0,124  0,115  Sphingosine 1-phosphate receptor 5 antagonist
0,037  0,028  Glutamate (mGluR8) agonist
0,017  0,010  Vitamin D receptor agonist
0,056  0,048  Carbamoyl phosphate synthetase inhibitor
0,051  0,044  Alcohol oxidase inhibitor
0,036  0,029  Delayed rectifier potassium channel blocker
0,124  0,117  GABA C receptor rho-2 antagonist
0,071  0,065  GABA B receptor agonist
0,100  0,093  Antiviral (SARS coronavirus)
0,100  0,093  Antiviral (Coronavirus)
0,030  0,024  Cholesterol ester transfer protein antagonist
0,092  0,086  Cystathionine beta-synthase inhibitor
0,035  0,029  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,048  0,042  Aconitate hydratase inhibitor
0,020  0,015  Retinoid X beta receptor agonist
0,008  0,003  Transcortin receptor antagonist
0,065  0,061  Porphobilinogen synthase inhibitor
0,044  0,040  Purinergic P2X antagonist
0,071  0,068  Chymotrypsin inhibitor
0,060  0,057  Calcium channel P-type blocker
0,086  0,083  Chronic obstructive bronchitis treatment
0,050  0,047  Sphingosine kinase 2 inhibitor
0,038  0,036  Kainate receptor agonist
0,039  0,037  Nicotinic receptor alpha3 subunit antagonist
0,025  0,024  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,036  0,035  Dopamine D5 agonist
0,045  0,044  Antiviral (Herpesvirus 3, Human)
0,030  0,030  Antihyperaldosteronism

